Quick Comparison
| Argireline (Acetyl Hexapeptide-3) | Glycolic Acid | |
|---|---|---|
| Typical Concentration | Typically used at 5-10% concentration. Apply twice daily to expression line areas (forehead, around eyes, between brows). Effects visible after 2-4 weeks. Must be used continuously — effects reverse when stopped. | Daily use: 5-10% at pH 3-4. Weekly peel: 10-30%. Professional peel: 30-70%. Start with 5% every other night. Increase concentration/frequency gradually. Always use SPF — AHAs increase sun sensitivity by up to 50%. Buffered formulations are gentler than free acid. |
| Application | Topical (serum, cream). Water-soluble. Apply directly to expression line areas. | Topical (toner, serum, peel, cleanser). Leave-on products are more effective than wash-off. Apply to dry skin at night. |
| Research Papers | 10 papers | 9 papers |
| Categories |
Mechanism of Action
Argireline (Acetyl Hexapeptide-3)
Argireline (acetyl hexapeptide-3) mimics the C-terminal region of SNAP-25, a core SNARE complex component. The SNARE complex (SNAP-25, syntaxin, synaptobrevin) mediates vesicle fusion at the neuromuscular junction for acetylcholine release. Argireline competes with SNAP-25 for syntaxin binding, partially disrupting SNARE assembly and reducing neurotransmitter exocytosis. This decreases acetylcholine release and attenuates facial muscle contraction intensity. The effect is dose-dependent, localized, and reversible—unlike botulinum toxin's enzymatic cleavage of SNAP-25. Clinical studies show ~30% wrinkle reduction versus 80%+ with injectable neurotoxins. Provides non-invasive expression line softening.
Glycolic Acid
Glycolic acid disrupts ionic bonds between corneocytes (dead skin cells) in the stratum corneum by chelating calcium ions and lowering the calcium concentration at desmosomal junctions. This weakens corneodesmosome integrity and activates endogenous proteases (kallikrein 5 and 7), accelerating desquamation. At higher concentrations, glycolic acid penetrates the viable epidermis and dermis, where it stimulates keratinocyte differentiation and upregulates transforming growth factor-beta (TGF-β) signaling in fibroblasts. This promotes glycosaminoglycan (GAG) synthesis, type I and III collagen production via procollagen gene expression, and elastin remodeling. Its small molecular size (76 Da) and high water solubility give it the deepest penetration of any AHA. The exfoliation also improves barrier function over time by promoting proper corneocyte maturation and reducing stratum corneum compaction.
Risks & Safety
Argireline (Acetyl Hexapeptide-3)
Common
Very well-tolerated. Occasional mild tingling.
Serious
None documented.
Rare
Allergic reaction. At very high concentrations, some users report a slight 'droopy' feeling in the treated area.
Glycolic Acid
Common
Stinging, redness, peeling, sun sensitivity. Over-exfoliation damages the skin barrier.
Serious
Chemical burns from professional-strength peels without proper protocol.
Rare
Scarring from improper high-concentration use.
Full Profiles
Argireline (Acetyl Hexapeptide-3) →
Known as 'topical Botox,' Argireline is a peptide that reduces the appearance of expression lines by partially inhibiting the SNARE complex — the same mechanism targeted by botulinum toxin, but through topical application rather than injection. The effect is much milder than Botox (roughly 30% wrinkle reduction vs 80%+) but provides a non-invasive option for forehead lines, crow's feet, and frown lines.
Glycolic Acid →
The smallest and most penetrating alpha-hydroxy acid (AHA). Derived from sugarcane, glycolic acid exfoliates by dissolving the bonds between dead skin cells on the surface, revealing smoother, brighter skin underneath. It is the most studied AHA with robust evidence for improving texture, fine lines, hyperpigmentation, and overall skin radiance. The gold standard chemical exfoliant.